Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

7.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same author

Hidradenitis Suppurativa Presenting with Ocular Manifestations in a 44-Year-Old Male: A Case Report.

Case reports in ophthalmology·2026
Same author

Transfusion reactions after whole blood transfusion in Norway, 2021-2024: A report from the Norwegian Hemovigilance program.

Transfusion·2026
Same author

Enzymatic DNA demethylation enables the formation of stable epimutations in tomato.

Journal of experimental botany·2026
Same author

Impact of CD19 CAR T-Cell Therapy on Pathogen-Specific Antibody Titers in Lymphoma Patients.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Progressive Bilateral Localised Amyloidosis of the Eyelids and Conjunctiva Four Years after MALT Lymphoma: A Case Report.

Klinische Monatsblatter fur Augenheilkunde·2026

Related Experiment Video

Updated: Oct 27, 2025

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
09:13

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis

Published on: January 5, 2024

1.5K

Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 Cells.

Daniel Cacic1, Oddmund Nordgård1, Peter Meyer1

  • 1Department of Hematology and Oncology, Stavanger University Hospital, 4068 Stavanger, Norway.

International Journal of Molecular Sciences
|July 24, 2021
PubMed
Summary
This summary is machine-generated.

Platelet microparticles (PMPs) shield acute myelogenous leukemia (AML) cells from chemotherapy-induced apoptosis. PMPs reduce DNA damage and downregulate the PUMA protein, enhancing AML cell survival.

Keywords:
acute myelogenous leukemiaapoptosismicroparticlesplatelets

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.2K
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.6K

Related Experiment Videos

Last Updated: Oct 27, 2025

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
09:13

Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis

Published on: January 5, 2024

1.5K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.2K
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.6K

Area of Science:

  • Hematology
  • Cancer Biology
  • Cellular Biology

Background:

  • Platelets and their microparticles (PMPs) influence cancer progression.
  • In acute myelogenous leukemia (AML), PMPs can confer chemoresistance by modulating cancer cell activity.
  • The specific mechanisms by which PMPs affect AML cell apoptosis remain incompletely understood.

Purpose of the Study:

  • To investigate whether PMPs protect the monocytic AML cell line THP-1 from apoptosis.
  • To determine if PMP internalization reduces cellular damage from daunorubicin or directly modulates the apoptotic response.
  • To elucidate the role of PMPs in intrinsic versus extrinsic apoptotic pathways in AML.

Main Methods:

  • Co-incubation of THP-1 cells with PMPs followed by treatment with apoptosis inducers.
  • Assessment of apoptosis sensitivity to intrinsic and extrinsic pathway activators.
  • Quantification of daunorubicin-induced DNA damage using gH2AX.
  • Analysis of BCL2-family protein expression, including PUMA.

Main Results:

  • PMP-mediated protection against apoptosis was specific to inducers of the intrinsic pathway.
  • PMP co-incubation significantly reduced daunorubicin-induced DNA damage (gH2AX levels) in both 2N and 4N cells.
  • PMPs downregulated the pro-apoptotic protein PUMA in response to daunorubicin treatment.

Conclusions:

  • PMPs protect AML cells from apoptosis by mitigating DNA damage, irrespective of cell cycle phase.
  • PMPs directly modulate the intrinsic apoptotic pathway by downregulating PUMA.
  • These findings highlight the significant clinical relevance of platelets and PMPs in AML pathogenesis and treatment resistance.